Literature DB >> 3973784

Screening for rubella IgG and IgM using an ELISA test applied to dried blood on filter paper.

J Sander, C Niehaus.   

Abstract

IgG and IgM rubella antibodies were measured in dried blood samples from the neonatal metabolic screening program. Of 6613 samples from four central screening laboratories, 289 did not contain rubella IgG antibodies, indicating that only 4.3% of the mothers at term were not immune to the rubella virus in the spring of 1984. The proportion of women at term who were not immune was 9.3% in 1979. Rubella IgM was detected in nine of 37,000 samples; congenital rubella infection was confirmed serologically in eight infants. Of the infected babies, three showed severe clinical findings. We suggest that rubella IgG and IgM should be determined regularly in the surplus material of metabolic screening centers, thus giving the opportunity to detect infected infants. The screening procedure is also useful as a serologic tool for monitoring immunity patterns in women, and thus the effectiveness of vaccination programs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973784     DOI: 10.1016/s0022-3476(85)80680-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Detection of rubella virus immunoglobulin G (IgG) and IgM antibodies in whole blood on Whatman paper: comparison with detection in sera.

Authors:  V Punnarugsa; V Mungmee
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Collection tubes with or without gel separator did not interfere with detection of rubella virus antibodies IgM and IgG.

Authors:  L C Oliveira; K H Kawasato; M S Otta; L P Lima; T S Okay
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence.

Authors:  M J Korndewal; A C T M Vossen; J Cremer; R S VAN Binnendijk; A C M Kroes; M A B VAN DER Sande; A M Oudesluys-Murphy; H E DE Melker
Journal:  Epidemiol Infect       Date:  2015-11-11       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.